OrganoORGJF 87 ROE % is 30.15% as of Mar. 2026, which is 138% above its 10-year median of 12.65. GuruFocus rates ORGJF with a GF Score™ of 87/100 and a GF Value™ of $56.75. The stock has 3 warning signs investors should review. Among 3,009 Industrial Products companies, Organo ranks better than 91.49% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Organo's annualized net income for the quarter that ended in Mar. 2026 was $262 Mil. Organo's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $870 Mil. Therefore, Organo's annualized ROE % for the quarter that ended in Mar. 2026 was 30.15%.
The historical rank and industry rank for Organo's ROE % or its related term are showing as below:
ORGJF'
s ROE % Range Over the Past 10 Years
Min: 5.54 Med: 12.65 Max: 22.1
Current: 22.1
During the past 13 years, Organo's highest ROE % was 22.10%. The lowest was 5.54%. And the median was 12.65%.
ORGJF's ROE % is ranked better than 91.49% of 3009
companies
in the Industrial Products industry
Industry Median: 5.91
vs ORGJF: 22.10
Organo (OTCPK:ORGJF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Organo ROE % Related Terms
Organo ROE % Historical Data
* Premium members only.
The historical data trend for Organo's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pollution & Treatment Controls subindustry, Organo's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organo ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Organo's ROE % distribution charts can be found below:
* The bar in red indicates where Organo's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Organo (ORGJF) has a ROE % of 30.15% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Organo and its competitors. This is 138% above median its historical median of 12.65. Over the past decade, Organo's ROE % has ranged from 5.54 to 22.10. According to the industry distribution chart, Organo ranks #256 out of 3009 companies in the Industrial Products industry, placing it in the top 8.5%.
Is Organo's ROE % too high?
Organo's current ROE % of 30.15% is 138% above median its 10-year median of 12.65. Over the past 10 years, this metric has ranged from a low of 5.54 to a high of 22.10. The Industrial Products industry median ROE % is 5.91. Organo's value of 30.15% is 410.2% above this industry median. Based on the distribution chart, Organo ranks #256 out of 3009 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Organo has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Organo's ROE % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Organo ranks #256 out of 3009 companies for ROE %. This places Organo in the top 9% of its industry — outperforming the majority of peers. The industry median ROE % is 5.91. Organo's value of 30.15% is 410.2% above this benchmark. Historically, Organo's own ROE % has ranged from 5.54 to 22.10 over the past decade. While the company's 10-year median is 12.65 vs. the industry median of 5.91, Organo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.91, based on 3,009 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Organo's current ROE % of 30.15% is 410.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Organo and its competitors. For the Industrial Products industry, the median ROE % is 5.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organo's current ROE % is 30.15%, which is 138% above median its own 10-year median of 12.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organo stock overvalued right now?
Organo (ORGJF) has a current ROE % of 30.15%. The stock's GF Value™ is $56.75, compared to a current price of $100.46 — trading 77% above its estimated fair value. The current ROE % is 30.15%, which is 138% above median its 10-year median of 12.65 and 410.2% above the Industrial Products industry median of 5.91. Organo's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Organo (ORGJF), the current ROE % is 30.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organo (ORGJF) Overvalued in 2026?
Based on GuruFocus' analysis, Organo stock appears to be overvalued.
The current stock price of $100.46 is trading 77% above its estimated GF Value™ of $56.75.
Key valuation signals for ORGJF:
ROE %: 30.15% (138% above median its 10-year median of 12.65)
GF Value™: $56.75 vs. price of $100.46 (77% above fair value)
Industry Position: 410.2% above the Industrial Products median (#256 of 3009)
No single metric tells the full story. See the ORGJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.
87GF Score
Get the complete analysis for ORGJF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORGJF has been successfully added to your 
